 |
Nick
Woolf
Chief Business Officer
Nick Woolf was appointed to the board of Oxford BioMedica in March 2005. He has extensive experience in investment banking and equity research in the biotechnology and pharmaceutical sectors. Nick joined Oxford BioMedica in 2002 from ABN AMRO, where he was a Director and Head of European Biotechnology Research. Prior to ABN AMRO, he was a Vice President and Senior European Biotechnology Analyst at Robertson Stephens, and was previously at both Nomura
and SBC Warburg. Nick is a qualified FCCA accountant and holds an MA in Chemistry from the University of Oxford.
|
Back
Website by College Hill - Life Sciences |
